Sociological and ethical issues in transplant commercialism

Current Opinion in Organ Transplantation

Volumn 14, Issue 2, 2009, Pages 134-139

  Epstein, Miran ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Commodification; Organ trafficking; Regulated market in organs; Transplant commercialism; Transplant tourism

Indexed keywords

HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; MEDICAL ETHICS; MEDICAL PRACTICE; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; REVIEW; COMMERCIAL PHENOMENA; COMPENSATION; ECONOMICS; ETHICS; GOVERNMENT REGULATION; HEALTH CARE DELIVERY; INTERNATIONAL COOPERATION; LEGAL ASPECT; LIVING DONOR; MOTIVATION; PATIENT RIGHT; SOCIOECONOMICS; TRANSPLANTATION; TRAVEL;

COMMERCE; COMPENSATION AND REDRESS; GOVERNMENT REGULATION; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; LIVING DONORS; MOTIVATION; ORGAN TRANSPLANTATION; PATIENT RIGHTS; SOCIOECONOMIC FACTORS; TISSUE AND ORGAN PROCUREMENT; TRAVEL;

EID: 67651037515     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283219d8e     Document Type: Review

References (65)

1. Shimazono Y. The state of the international organ trade: a provisional picture based on integration of available information. Bull World Health Organ 2007; 85:955-962. This study not only provides an updated estimate of transplant commercialism but also conceptualizes and depicts the distinct modes of its global variant. (Pubitemid 350248408)
2. Budiani-Saberi DA, Delmonico FL. Organ trafficking and transplant tourism: a commentary on the global realities. Am J Transplant 2008; 8:925-929. This commentary outlines the basic principles of the campaign against global transplant commercialism. Indeed, these principles have been incorporated into the major international documents almost verbatim.
3. Leung G. Fun, sun, get a surgery done! The growing trend of transplant tourism. Issues Berkeley Med J 2006; 13:7-8.
4. Milstein A, Smith M. America's new refugees: seeking affordable surgery offshore. N Engl J Med 2006; 355:1637-1640. (Pubitemid 44583952)
5. Watkins C. 3 ways to cash in on the growth of offshore surgery alternatives. Managed Care Rep 2006; 21:146-149.
6. Bramstedt KA, Xu J. Checklist: passport, plane ticket, organ transplant. Am J Transplant 2007; 7:1698-1701. (Pubitemid 46905437)
7. Freeman RB. 'Transplant tourism' in the United States? Transplantation 2007; 84:1559-1560.
8. Delmonico FL. The Pakistani revelation. Transplant Int 2007; 20:924-925.
9. UNOS board further addresses transplant tourism; 2007. http://www.unos. org/newsDetail.asp?id=891. [Accessed 30 October 2008].
10. Merion RM, Barnes AD, Lin M, et al. Transplants in foreign countries among patients removed from the US transplant waiting list. Am J Transplant 2008; 4:988-996.
11. Surman OS, Saidi R, Purtilo R, et al. The market of human organs: a window into a poorly understood global business. Transplant Proc 2008; 40:491-493.
12. Turner L. Let's wave goodbye to 'transplant tourism'. BMJ 2008; 336:1377.
13. Budiani-Saberi DA, Delmonico FL. Response to: Will transplant tourism erode the surgical skills of transplant surgeons in Israel? Am J Transplant 2008; 8:1964.
14. Prasad GV, Shukla A, Huang M, et al. Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 2006; 82:1130-1135. (Pubitemid 44748012)
15. Canales MT, Kasiske BL, Rosenberg ME. Transplant tourism: outcomes of United States residents who undergo kidney transplantation overseas. Transplantation 2006; 82:1658-1661.
16. Levine GN, Port FK, Burdick J. Transplants in foreign countries among patients removed from the US transplant waiting list. Am J Transplant 2008; 8:988-996.
17. Gill J, Madhira BR, Gjertson D, et al. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol 2008; 3:1820-1828.
18. Noorani MA. Commercial transplantation in Pakistan. BMJ 2008; 336:1378.
19. Budiani D. Consequences of living kidney donors in Egypt. Presentation at the Middle East Society on Organ Transplants (Mesot) meetings; November 2006; Kuwait.
20. Naqvi SAA, Ali B, Mazhar F, et al. A socioeconomic survey of kidney vendors in Pakistan. Transpl Int 2007; 20:934-939. (Pubitemid 47537569)
21. Naqvi SAA, Rizvi SAH, Zafar MN, et al. Health status and renal function evaluation of kidney vendors: a report from Pakistan. Am J Transplant 2008; 8:1444-1450.
22. Sajjad I, Baines LS, Patel P, et al. Commercialization of kidney transplants: a systematic review of outcomes in recipients and donors. Am J Nephrol 2008; 28:744-754.
23. Israel Transplant Law 2008 [17/68, in Hebrew]; 2008. http://www.knesset. gov.il/privatelaw/data/17/3/68-3-1.rtf. [Accessed 30 October 2008].
24. Medical tourism plans for Cebu pushed. Cebu Daily News 6 August 2007. http://globalnation.inquirer.net/cebudailynews/news/view-article.php?article-id= 80868. [Accessed 30 October 2008].
25. Republic of the Philippines, Department of Health, Office of the Secretary. Revised national policy on kidney transplantation from living nonrelated organ donor and its implementing structures. Administrative Order No. 2008-0004; 2008.
26. Philippine Society of Nephrology. Statement on Department of Health Administrative Order 2008-0004; 2008.
27. The Transplantation Society and the International Society of Nephrology. The Transplantation Society and the International Society of Nephrology support the Philippine Society of Nephrology. Letter sent to the Philippine Government and the office of the President; 2008.
28. Steering Committee of the Istanbul Summit. Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul. Lancet 2008; 372:5-6. This document enshrines the principles of the international campaign against transplant commercialism with special reference to its global variant.
29. WHO. WHO guiding principles on human cell, tissue and organ transplantation. EB123/5 2008:1-8. Another document that reaffirms the principles of the international campaign against transplant commercialism and global transplant commercialism in particular.
30. Evans RW. Ethnocentrism is an unacceptable rationale for healthcare policy: a critique of transplant tourism position statements. Am J Transplant 2008; 8:1089-1095.
31. Stephan A, Barbari A, Younan F. Ethical aspects of organ donation activities. Exp Clin Transplant 2007; 5:633-637. (Pubitemid 351146917)
32. Laurance J. Surgeon: organ trade should be legalized. The Independent 13 June 2008. http://www.independent.co.uk/life-style/health-and-wellbeing/ health-news/surgeon-organ-trade-should-be-legalised-846234.html. [Accessed 30 October 2008].
33. Danovitch GM, Leichtman AB. Kidney vending: the 'Trojan horse' of organ transplantation. Clin J Am Soc Nephrol 2006; 1:1133-1135.
34. Satel S, Hakim N. 'What's wrong with selling kidneys?' International Herald Tribune 20 June 2008. http://www.iht.com/articles/2008/06/20/opinion/ edsatel.php. [Accessed 30 October 2008].
35. Brennan T. Markets in healthcare: the case of renal transplantation. J Law Med Ethics 2007; 35:249-255.
36. Novelli G, Rossi M, Poli L, et al. Is legalizing the organ market possible? Transplant Proc 2007; 39:1743-1745.
37. Erin CA, Harris J. A monopsonistic market: or how to buy and sell human organs, tissues and cells ethically. In: Robinson I, editor. Life and death under high technology medicine. Manchester: Manchester University Press in association with the Fulbright Commission, London; 1994. pp. 134-153.
38. Friedman AL. Payment for living organ donation should be legalized. BMJ 2006; 333:746-748. (Pubitemid 44555174)
39. Friedman E, Friedman AL. Payment for donor kidneys: pros and cons. Kidney Int 2006; 69:960-962. (Pubitemid 43372168)
40. Daar AS. The case for a regulated system of living kidney sales. Nat Clin Pract Nephrol 2006; 2:600-601. (Pubitemid 44655630)
41. Hippen B. The case for kidney markets. The New Atlantis Fall 2006:47-61. http://www.thenewatlantis.com/archive/14/TNA14-Hippen.pdf. [Accessed 30 October 2008].
42. Satel S. Paying for kidneys. The Washington Post 30 April 2007. http:// www.washingtonpost.com/wp-dyn/content/article/2007/04/29/ AR2007042901321.html. [Accessed 30 October 2008].
43. Abouna GM. Organ shortage crisis: problems and possible solutions. Transplant Proc 2008; 40:34-38. (Pubitemid 351186663)
44. Matas AJ. Should we pay donors to increase the supply of organs for transplantation? Yes. BMJ 2008; 336:1342.
45. Godlee F. Is it time to pilot paying for organs? BMJ 2008; 336.
46. Epstein M. The ethics of poverty and the poverty of ethics: the case of Palestinian prisoners in Israel seeking to sell their kidneys in order to feed their children. J Med Ethics 2007; 33:473-474.
47. Garwood P. Dilemma over live-donor transplantation. Bull World Health Organ 2007; 85:1-84.
48. Chapman J. Should we pay donors to increase the supply of organs for transplantation? No. BMJ 2008; 336:1343. (Pubitemid 351914621)
49. Danovitch GM. The doctor/patient relationship in living donor kidney transplantation. Curr Opin Nephrol Hypertens 2007; 16:503-505. (Pubitemid 350293739)
50. Paramesh AS, Killackey MT, Zhang R, et al. Living donor kidney transplantation: medical, legal, and ethical considerations. South Med J 2007; 100: 1208-1213. (Pubitemid 350304826)
51. Danovitch GM. Cultural barriers to kidney transplantation: a new frontier. Transplantation 2007; 84:462-463. (Pubitemid 47312154)
52. Zargooshi J. Iran's commercial renal transplantation program: results and complications. In: Weimar W, Boss MA, Busschbach JJ, editors. Organ transplantation: ethical, legal and psychosocial aspects. Lengerich: Pabst Science Publishers; 2008. pp. 80-94.
53. Danovitch GM. Who cares? A lesson from Pakistan on the health of living donors. Am J Transplant 2008; 8:1-2.
54. Danovitch GM, Delmonico FL. The prohibition of kidney sales and organ markets should remain. Curr Opin Organ Transplant 2008; 13:386-394.
55. Delmonico FL, Danovitch GM. Regulated market for organs is unattainable. Minn Med 2008; 91:6.
56. Epstein M. The Declaration of Istanbul on Organ Trafficking and Transplant Tourism: an important international achievement with one disturbing loophole. BMJ 2008. http://www.bmj.com/cgi/eletters?lookup=by-date&days= 1#198338. [Accessed 30 October 2008].
57. Epstein M, Danovitch GM. Is altruistic-directed living unrelated organ donation a legal fiction? Nephrol Dial Transplant 2009; 24:357-360.
58. Beier UH, Hidalgo G, John E. Financial incentives to promote prolonged renal graft survival: potential for patients and public health. Med Hypotheses 2008; 70:218-220. (Pubitemid 350297630)
59. The gap between supply and demand. The Economist 11-17 October 2008:85-87.
60. Monaco AP. Rewards for organ donation: the time has come. Kidney Int 2006; 69:955-957. (Pubitemid 43372166)
61. Matas AJ. A gift of life deserves compensation: how to increase living kidney donation with realistic incentives. Cato Institute Policy Analysis 2007; 604:15.
62. Clamon JB. Tax policy as a lifeline: encouraging blood and organ donation through tax credits. Ann Health Law 2008; 17:67-99.
63. Kranenburg L, Schram A, Zuidema W, et al. Public survey of financial incentives for kidney donation. Nephrol Dial Transplant 2008; 23:1039-1042. (Pubitemid 351767547)
64. Organ Donation Clarification Act of 2008: Proposed Specter Bill. 8 September 2008. http://www.asts.org/Advocacy/Legislative.aspx. [Accessed 30 October 2008].
65. Epstein M, Danovitch G. Is altruistic-directed living unrelated organ donation a legal fiction? Nephrol Dial Transplant 2009; 24:357-360.